SCHEMBL7714320

SCHEMBL7714320

N[C@@H](CC(=O)O)c1ccccc1-c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.43
BCAT2 O15382 1/20 0.43
CASP1 P29466 1/20 0.41
GABBR2 O75899 1/20 0.41
GABBR1 Q9UBS5 1/20 0.41
SLC1A3 P43003 1/20 0.40
SLC1A2 P43004 1/20 0.40
SLC1A1 P43005 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
CYP1A2 P05177 1/20 0.40
TSHR P16473 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
MMP2 P08253 1/20 0.39
MMP9 P14780 1/20 0.39
MMP12 P39900 1/20 0.39
MMP13 P45452 1/20 0.39
MMP14 P50281 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20545885 0.87 CD274 (0.47) KMT2ABCAT2SLC1A3SLC1A2SLC1A1
SCHEMBL20545887 0.87 CD274 (0.47) KMT2ABCAT2SLC1A3SLC1A2SLC1A1
SCHEMBL20546385 0.85 CTSA (0.41) KMT2ABCAT2CASP1SMN1; SMN2CTSA
SCHEMBL20546383 0.85 CTSA (0.41) KMT2ABCAT2CASP1SMN1; SMN2CTSA
SCHEMBL11397704 0.80 KMT2A (0.44) KMT2ABCAT2CASP1GABBR2GABBR1
SCHEMBL11487567 0.79 PTGER1 (0.53) KMT2ACASP1CYP1A2TSHRSMN1; SMN2
SCHEMBL2320843 0.78 CTSA (0.47) GABBR2GABBR1CTSA
SCHEMBL5720952 0.78 CTSA (0.47) GABBR2GABBR1CTSA
SCHEMBL31757740 0.78 AKR1B1 (0.44) KMT2AGABBR2GABBR1CYP1A2TSHR
SCHEMBL5597477 0.78 AKR1B1 (0.44) KMT2AGABBR2GABBR1CYP1A2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6432923-B1 ANTIINFLAMMATORY AGENTS; AUTOIMMUNE DISEASES NOVARTIS AG (CH) 2002-08-13 US disclosed